Trial Profile
A clinical trial of Lucitanib in combination with a PD-1 inhibitor
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 Aug 2018
Price :
$35
*
At a glance
- Drugs Lucitanib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 10 Aug 2018 New trial record
- 01 Aug 2018 According to a Clovis Oncology media release, the company is planning to initiate this trial before the end of Q1 2019.